Source link : https://www.newshealth.biz/health-news/glp-1-drugs-cut-glaucoma-risk-in-nondiabetic-obesity/
TOPLINE: In patients without diabetes diagnosed with overweight or obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) led to a greater reduction in the risks for primary open-angle glaucoma and ocular hypertension at 3 and 5 years of treatment compared with alternative medications for weight loss. METHODOLOGY: Researchers conducted a retrospective cohort […]
Author : News Health
Publish date : 2025-02-25 10:01:26
Copyright for syndicated content belongs to the linked Source.